Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V From July 1, 2026

Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V From July 1, 2026. Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Betamethasone + Salicylic Acid In The Dosage Form Loe,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brivaracetam,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Cyproterone,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydroxyzine,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Meloxicam,Conclusion Of Non-Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Salbutamol Without Any Preparations On The List According To Section 35 Paragraph 5A Sgb V,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Fat Emulsions In The Context Of Parenteral Nutrition (Atc Code B05 Ba 02).,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V On Electrolytes In Combinations As Part Of Parenteral Nutrition (Atc Code B05 Xa 31).